Phi-53: (NCI#7251): Phase I trial of belinostat (PXD101) in combination with 13-cis-retinoic acid (13c-RA) in advanced solid tumor malignancies—A California Cancer Consortium NCI/CTEP sponsored trial.
Thehang H. Luu
No relevant relationships to disclose
Paul Henry Frankel
No relevant relationships to disclose
Dean Lim
No relevant relationships to disclose
Mihaela C. Cristea
No relevant relationships to disclose
Jan Hendrik Beumer
No relevant relationships to disclose
Leonard Joseph Appleman
No relevant relationships to disclose
Heinz-Josef Lenz
No relevant relationships to disclose
David R. Gandara
No relevant relationships to disclose
Richard Piekarz
No relevant relationships to disclose
Edward M. Newman
No relevant relationships to disclose